These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25053452)

  • 21. Monitoring the 2001 Declaration of Commitment on HIV/AIDS.
    Warner-Smith M; Rugg D; Frescura L; Moussavi S
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S77-86. PubMed ID: 19901630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study.
    Rodi P; Obermeyer W; Pablos-Mendez A; Gori A; Raviglione MC
    PLoS Med; 2022 Jan; 19(1):e1003873. PubMed ID: 35025880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of mental health and substance abuse factors on HIV prevention and treatment.
    Walkup J; Blank MB; Gonzalez JS; Safren S; Schwartz R; Brown L; Wilson I; Knowlton A; Lombard F; Grossman C; Lyda K; Schumacher JE
    J Acquir Immune Defic Syndr; 2008 Mar; 47 Suppl 1():S15-9. PubMed ID: 18301129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Southern Harm Reduction Coalition for HIV Prevention: Advocacy Accomplishments.
    Story CR; ; Kao WK; Currin J; Brown C; Charles V
    Health Promot Pract; 2018 Sep; 19(5):695-703. PubMed ID: 29186992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global health policy.
    Doryan EA; Lovelace JC
    Lancet; 2000 Aug; 356(9230):679-80. PubMed ID: 10968460
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of HIV prevention programs on drug users in Malaysia.
    Kamarulzaman A
    J Acquir Immune Defic Syndr; 2009 Nov; 52 Suppl 1():S17-9. PubMed ID: 19858930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of HIV prevention interventions for people who inject drugs in low- and middle-income countries--the current and future state of the art.
    Hammett TM; Parsons DS
    Int J Drug Policy; 2014 May; 25(3):336-9. PubMed ID: 24559603
    [No Abstract]   [Full Text] [Related]  

  • 29. Human rights: a critical framework for the response to HIV/AIDS.
    McLellan F
    Lancet; 2001 Jul; 358(9276):144. PubMed ID: 11463436
    [No Abstract]   [Full Text] [Related]  

  • 30. International drug control system and the United Nations General Assembly Special Session (UNGASS) on the world drug problem: an overview.
    Niaz K
    East Mediterr Health J; 2017 May; 23(3):143-149. PubMed ID: 28493260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug crime and criminalisation threaten progress on MDGs.
    Morris K
    Lancet; 2010 Oct; 376(9747):1131-2. PubMed ID: 20922837
    [No Abstract]   [Full Text] [Related]  

  • 32. Can the Success of HIV Scale-Up Advance the Global Chronic NCD Agenda?
    Palma AM; Rabkin M; Nuwagaba-Biribonwoha H; Bongomin P; Lukhele N; Dlamini X; Kidane A; El-Sadr WM
    Glob Heart; 2016 Dec; 11(4):403-408. PubMed ID: 27938826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global drug policy at an impasse: Examining the politics of the 2016 United Nations General Assembly Special Session.
    Sischy J; Blaustein J
    Int J Drug Policy; 2018 Oct; 60():74-81. PubMed ID: 30173003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. About harm reduction in the context of the response to HIV/AIDS.
    Can HIV AIDS Policy Law Rev; 2004 Aug; 9(2):5. PubMed ID: 15540323
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact Evaluation of a Policy Intervention for HIV Prevention in Washington, DC.
    Ruiz MS; O'Rourke A; Allen ST
    AIDS Behav; 2016 Jan; 20(1):22-8. PubMed ID: 26336945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public health. China partners with gay groups on HIV screening.
    Hvistendahl M
    Science; 2013 Jan; 339(6115):17-8. PubMed ID: 23288517
    [No Abstract]   [Full Text] [Related]  

  • 37. PEPFAR's evolving HIV prevention approaches for key populations--people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities.
    Needle R; Fu J; Beyrer C; Loo V; Abdul-Quader AS; McIntyre JA; Li Z; Mbwambo JK; Muthui M; Pick B
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S145-51. PubMed ID: 22797736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Global State of Harm Reduction in Prisons.
    Sander G; Shirley-Beavan S; Stone K
    J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV and women who use drugs: double neglect, double risk.
    El-Bassel N; Terlikbaeva A; Pinkham S
    Lancet; 2010 Jul; 376(9738):312-4. PubMed ID: 20650519
    [No Abstract]   [Full Text] [Related]  

  • 40. Human rights and universal access for men who have sex with men and people who inject drugs: a qualitative analysis of the 2010 UNGASS narrative country progress reports.
    Persson A; Ellard J; Newman C; Holt M; de Wit J
    Soc Sci Med; 2011 Aug; 73(3):467-74. PubMed ID: 21764488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.